Safety and Improved Clinical Outcomes in Patients Treated With New Equine-Derived Heptavalent Botulinum Antitoxin
Patricia Yu(Centers for Disease Control and Prevention), Agam K. Rao, Jennifer N. Clements(Centers for Disease Control and Prevention), Hye-Joo Kim(Centers for Disease Control and Prevention), Yon Yu(Department of Human Services), Weidong Gu(Centers for Disease Control and Prevention), Neal H. Lin(Centers for Disease Control and Prevention), Rajal K. Mody(National Center for Emerging and Zoonotic Infectious Diseases), Barbara E. Mahon(Boston University), Jeremy Sobel(National Center for Infectious Diseases)
Cited by 98
Related Papers
An International Outbreak of<i>Salmonella</i>Infections Caused by Alfalfa Sprouts Grown from Contaminated Seeds
|The Journal of Infectious Diseases|1997|329
Monkeypox Outbreak — Nine States, May 2022
|MMWR Morbidity and Mortality Weekly Report|2022|309
Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years — United States, March 1, 2020–June 28, 2021
|MMWR Morbidity and Mortality Weekly Report|2022|298
An assessment of the human health impact of seven leading foodborne pathogens in the United States using disability adjusted life years
|Epidemiology and Infection|2015|295